NCT00521365 Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. Status COMPLETED Phase PHASE4
NCT00520507 An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients Status COMPLETED Phase PHASE4
NCT00512616 A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder Status WITHDRAWN Phase PHASE2
NCT00512070 Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine Status COMPLETED Phase NA
NCT00510211 An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. Status COMPLETED Phase N/A
NCT00501865 Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT00490971 A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00490542 Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State Status COMPLETED Phase PHASE2
NCT00488618 Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania Status COMPLETED Phase PHASE2
NCT00488566 GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00486798 FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis Status TERMINATED Phase PHASE3
NCT00485771 Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression Status COMPLETED Phase PHASE4
NCT00485680 Olanzapine Versus Comparator in the Treatment of Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00484471 ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness Status COMPLETED Phase PHASE4
NCT00483548 Adjunctive Ziprasidone in the Treatment of Bipolar I Depression Status COMPLETED Phase PHASE3